(Q37756576)

22 August 2017

1 reference

title

Osteoporosis and inflammation (English)

1 reference

22 August 2017

0 references

0 references

Paulo Gustavo Sampaio Lacativa

series ordinal

1

1 reference

22 August 2017

Maria Lucia Fleiuss de Farias

series ordinal

2

1 reference

22 August 2017

publication date

1 March 2010

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

22 August 2017

published in

1 reference

22 August 2017

volume

54

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

123-132

1 reference

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Osteoclasts: what do they do and how do they do it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

The role of T lymphocytes in bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Osteoblasts and osteoclasts in bone remodeling and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

The pathophysiologic roles of interleukin-6 in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Chronic pediatric inflammatory diseases: effects on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Osteoporosis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Altered bone metabolism in inflammatory disease: role for nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

How can we prevent multisystem complications of cystic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Office practice of osteoporosis evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Guide to bone health and disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Vitamin K supplementation in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Growth hormone improves bone mineral content in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Extra-skeletal effects of bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Role of RANKL inhibition in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Antibody treatments of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Geneva Biology of Ageing Workshop 2000: phagocytes, inflammation, and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Inflammation Is The Main Determinant of Low Bone Mineral Density in Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302010000200007

10.1590/S0004-27302010000200007

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference